These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 33678738)

  • 1. Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis.
    Hamada N; Ishiga M; Tanaka S; Ooue Y; Itano J; Tanaka H; Yuzurio S; Horiuchi T; Suwaki T; Kimura G; Tanimoto Y
    Intern Med; 2021 Aug; 60(15):2465-2468. PubMed ID: 33678738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of invasive pulmonary aspergillosis with a fungus ball and infiltration by the long-term administration of liposomal amphotericin B].
    Hataji O; Komada F; Kobayashi H; Taguchi O
    Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):496-500. PubMed ID: 21842685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
    Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
    Wu H; Xiong X; Han Q; Zhuo K; Wang K; Cheng D
    J Mycol Med; 2023 Aug; 33(3):101385. PubMed ID: 37031653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot study of intermittent administration of liposomal amphotericin B for chronic pulmonary aspergillosis].
    Fujita M; Hirano R; Matsumoto T; Watanabe K
    Jpn J Antibiot; 2014 Jun; 67(3):205-10. PubMed ID: 25163253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
    Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
    Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
    CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
    Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
    Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B (AmBisome).
    Watanabe A; Matsumoto K; Igari H; Uesato M; Yoshida S; Nakamura Y; Morita K; Shibuya K; Matsubara H; Yoshino I; Kamei K
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e220-3. PubMed ID: 19959388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
    López-Sánchez A; Pérez-Cantero A; Torrado-Salmerón C; Martin-Vicente A; García-Herrero V; González-Nicolás MÁ; Lázaro A; Tejedor A; Torrado-Santiago S; García-Rodríguez JJ; Capilla J; Torrado S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunocompetent case of chronic pulmonary aspergillosis caused by Aspergillusviridinutans.
    Hamada N; Okawa S; Ishiga M; Yuzurio S; Suwaki T; Yaguchi T; Kimura G; Tanimoto Y
    Respir Investig; 2024 Jan; 62(1):164-166. PubMed ID: 38141529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary aspergillus infection with abnormal imaging successfully treated with omalizumab: A case report.
    He X; Chang Z; Yan H; Weng Y
    Medicine (Baltimore); 2023 Jun; 102(24):e33845. PubMed ID: 37327273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Nakaya Y; Nakashima Y; Harada N; Yamada K; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Nanno S; Nishimoto M; Koh H; Nakagama Y; Kido Y; Kanno T; Suzuki T; Nakamae H; Kakeya H; Hino M
    J Infect Chemother; 2023 Feb; 29(2):223-227. PubMed ID: 36379403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life.
    Chong GL; Broekman F; Polinder S; Doorduijn JK; Lugtenburg PJ; Verbon A; Cornelissen JJ; Rijnders BJ
    Int J Antimicrob Agents; 2015 Jul; 46(1):82-7. PubMed ID: 25956843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
    Hashimoto M; Honda Y; Fujishima T
    Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
    Person AK; Chudgar SM; Norton BL; Tong BC; Stout JE
    J Med Microbiol; 2010 Jul; 59(Pt 7):834-838. PubMed ID: 20299503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
    Kirkpatrick WR; Coco BJ; Patterson TF
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.